Business Wire (September 14, 1998)
Permanent Link:
http://vlex.com/vid/techniclone-submits-tnt-protocol-fda-53849383
Id. vLex: VLEX-53849383
Acceda a este documento
y pruebe vLex GRATIS durante 3 días
Techniclone Submits Phase II TNT Protocol to FDA.
TUSTIN, Calif.--(BUSINESS WIRE)--Sept. 14, 1998--
-- Multi-Center Investigational Study to Assess Efficacy in Patinets with Malignant Glioma (Brain Cancer) -- Techniclone Corp. (NASDAQ: TCLN) a developer of ...Try vLex for FREE for 3 days
Access legal information from United States including:
Try vLex without any commitment for 3 days and see why you need it.
3
days of Free Access
If you are already a vLex customer, Access Here